Skip to content
OpenCapital
Get started

The RealReal REAL Indefinite-Lived Research and Development Assets

Indefinite-Lived Research and Development Assets at other companies

HTF
Heartflow, Inc. Common StockHTFL
$15.41M-25.5%
Photronics logo
PhotronicsPLAB
$3.9M+43.5%
KEE
Keel Infrastructure Corp. Common StockKEEL
$2.19M-50.8%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$7.96M-63.4%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$6.19M-79.2%
BlackSky Technology logo
BlackSky TechnologyBKSY
$8.38M-29.4%

Other financials

Income statement

See full
Revenue$189.7M+18.5%
Gross profit$141.3M+17.8%
Operating income-$2.3M+82.2%
Net income$38.9M-37.6%
EPS (diluted)-$0.07+50.0%

Balance sheet

See full
Cash & equivalents$138.8M-10.2%
Total debt$233.4M-13.4%
Total equity-$359.4M-6.9%
Total assets$385.9M-3.6%

Cash flow

See full
Operating cash flow-$16.6M+41.2%
CapEx$7.5M+58.5%
Free cash flow-$24.1M+26.9%

Valuation

See full
Market cap$1.55B+169%
Enterprise value$1.64B+138%
P/S2.1×+1.2×

Profitability

See full
Gross margin74.5%-0.2pp
Operating margin-5.3%-1.9pp
Net margin-9%+5.3pp
FCF margin3.8%+2.7pp

Returns & leverage

See full
Return on equity-178.6%—
Debt / equity2.2×—
Current ratio0.8×0.0×

Where this comes from

Reported directly by The RealReal in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment.

The official record: The RealReal’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about The RealReal's indefinite-lived research and development assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The RealReal's indefinite-lived research and development assets?
The RealReal (REAL) reported indefinite-lived research and development assets of $13.94M in Q4 2025.
How has The RealReal's indefinite-lived research and development assets changed year-over-year?
The RealReal's indefinite-lived research and development assets decreased by 25.4% year-over-year, from $18.68M to $13.94M.
What does indefinite-lived research and development assets mean?
These are acquired in-process research and development assets that are not currently amortized because their useful life cannot be determined until the underlying technology is fully developed or abandoned. This metric represents the value of innovation pipelines that have not yet reached commercialization. It is a key indicator of the company's investment in future product capabilities and long-term competitive positioning.